RedHill Biopharma (RDHL) Change in Account Payables (2016 - 2022)
RedHill Biopharma (RDHL) posted quarterly Change in Account Payables of -$554000.0 for Q4 2022, up 84.53% year-over-year from -$300223.1 in Q4 2021, and down 234.79% quarter-over-quarter from $411000.0 in Q3 2022.
RedHill Biopharma (RDHL) Change in Account Payables (2016 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported Change in Account Payables for 7 consecutive years, with -$554000.0 the latest figure, recorded in Q4 2022.
- In Q4 2022, Change in Account Payables rose 84.53% year-over-year to -$554000.0; the TTM figure through Dec 2022 stood at -$7.4 million (down 6797.3% YoY), while the FY2025 annual figure was -$437000.0, up 79.29% from the prior year.
- Change in Account Payables slipped to -$554000.0 in Q4 2022 per RDHL's latest filing, from $411000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.8 million in Q2 2021 and bottomed at -$6.0 million in Q1 2022.
- Historically, Change in Account Payables has averaged -$28750.0 across 5 years, with a median of -$52500.0 in 2018.
- Annual changes were most pronounced in 2018 — Change in Account Payables plunged 5235.9% — and 2020, when it soared 2372.55%.
- RedHill Biopharma's Change in Account Payables stood at -$543000.0 in 2018, then decreased by 12.34% to -$610000.0 in 2019, then soared by 917.05% to $5.0 million in 2020, then plunged by 171.85% to -$3.6 million in 2021, then jumped by 84.53% to -$554000.0 in 2022.
- Business Quant data shows RDHL's Change in Account Payables at -$554000.0 in Q4 2022, $411000.0 in Q3 2022, and -$1.3 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -554,000.00 |
| Dec 31, 2022 | -554,000.00 |
| Sep 30, 2022 | 411,000.00 |
| Sep 30, 2022 | 411,000.00 |
| Jun 30, 2022 | -1.33 Mn |
| Jun 30, 2022 | -1.33 Mn |
| Mar 31, 2022 | -5.96 Mn |
| Mar 31, 2022 | -5.96 Mn |
| Dec 31, 2021 | -3.58 Mn |
| Dec 31, 2021 | -3.58 Mn |
| Sep 30, 2021 | 1.94 Mn |
| Sep 30, 2021 | 1.94 Mn |
| Jun 30, 2021 | 6.77 Mn |
| Jun 30, 2021 | 6.77 Mn |
| Mar 31, 2021 | -5.02 Mn |
| Mar 31, 2021 | -5.02 Mn |
| Dec 31, 2020 | 4.98 Mn |
| Dec 31, 2020 | 4.98 Mn |
| Sep 30, 2020 | 1.26 Mn |
| Sep 30, 2020 | 1.26 Mn |